BPTH Bio-Path Holdings, Inc.

0.69
0  -3%
Previous Close 0.71
Open 0.72
Price To book 8.25
Market Cap 66.00M
Shares 95,645,000
Volume 68,029
Short Ratio 24.90
Av. Daily Volume 141,394

SEC filingsSee all SEC filings

  1. 8-K - Current report 17764146
  2. 8-K - Current report 17742207
  3. 8-K - Current report 17689820
  4. 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17689796
  5. 8-K - Current report 17681972

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 first patient enrolled November 2016.
BP-1001
Acute myeloid leukemia (AML)

SEC Filings

  1. 8-K - Current report 17764146
  2. 8-K - Current report 17742207
  3. 8-K - Current report 17689820
  4. 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17689796
  5. 8-K - Current report 17681972
  6. 8-K - Current report 17675265
  7. 8-K - Current report 17625412
  8. 8-K - Current report 17582175
  9. 424B5 - Prospectus (Rule 424(b)(5)) 17521230
  10. 424B5 - Prospectus (Rule 424(b)(5)) 17521145